BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10661741)

  • 1. Collaboration with academia in the development of vaginal microbicides.
    Upmalis DH
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S55-8. PubMed ID: 10661741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promise of public/private sector collaboration in the development of vaginal microbicides.
    Gabelnick HL; Harper MJ
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S31-8. PubMed ID: 10661739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.
    Barnhart KT; Rosenberg MJ; MacKay HT; Blithe DL; Higgins J; Walsh T; Wan L; Thomas M; Creinin MD; Westhoff C; Schlaff W; Archer DF; Ayers C; Kaunitz A; Das S; Moench TR
    Obstet Gynecol; 2007 Sep; 110(3):577-86. PubMed ID: 17766603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Patentex Oval N - a modern local contraceptive].
    Libra Pharma.
    Akush Ginekol (Sofiia); 2000; 39 Suppl 2():26-7. PubMed ID: 11188013
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of an optimized benzalkonium chloride gel as vaginal contraceptive: a randomized controlled trial among Chinese women.
    Li W; Huang Z; Wu Y; Wang H; Zhou X; Xiao Z; Ding X; Xu J
    Contraception; 2013 Jun; 87(6):756-65. PubMed ID: 23089047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Easing the way to safer sex.
    Larkin M
    Lancet; 1998 Mar; 351(9107):964. PubMed ID: 9734955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe chemical cystitis from the transurethral intravesical insertion of a vaginal contraceptive suppository: a report of 3 cases and proposed method of management.
    Mayersak JS; Viviano CJ
    J Urol; 1993 Apr; 149(4):835-7. PubMed ID: 8384272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptive effectiveness and safety of five nonoxynol-9 spermicides: a randomized trial.
    Raymond EG; Chen PL; Luoto J;
    Obstet Gynecol; 2004 Mar; 103(3):430-9. PubMed ID: 14990402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female controlled methods of contraception and sexually transmitted infections including HIV in Malawi: examining the role of the female condom and microbicides.
    Bisika T
    East Afr J Public Health; 2009 Aug; 6(2):223-5. PubMed ID: 20000034
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of a new vaginal contraceptive.
    Stone SC; Cardinale F
    Am J Obstet Gynecol; 1979 Mar; 133(6):635-8. PubMed ID: 233541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers.
    Marais D; Carrara H; Kay P; Ramjee G; Allan B; Williamson AL
    Virus Res; 2006 Nov; 121(2):220-2. PubMed ID: 16860426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonprescription vaginal contraception.
    Edelman DA
    Int J Gynaecol Obstet; 1980; 18(5):340-4. PubMed ID: 6110578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OTC Product: Today Sponge.
    Mehta BH
    J Am Pharm Assoc (2003); 2006; 46(2):304. PubMed ID: 16602236
    [No Abstract]   [Full Text] [Related]  

  • 14. Spermicides, HIV, and the vaginal sponge.
    Stone KM; Peterson HB
    JAMA; 1992 Jul 22-29; 268(4):521-3. PubMed ID: 1320135
    [No Abstract]   [Full Text] [Related]  

  • 15. Mucosal integrity and inflammatory markers in the female lower genital tract as potential screening tools for vaginal microbicides.
    Su HI; Schreiber CA; Fay C; Parry S; Elovitz MA; Zhang J; Shaunik A; Barnhart K
    Contraception; 2011 Nov; 84(5):525-32. PubMed ID: 22018129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol-9 containing intravaginal contraceptives.
    Witter FR; Barditch-Crovo P; Rocco L; Trapnell CB
    Int J Gynaecol Obstet; 1999 May; 65(2):165-70. PubMed ID: 10405061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-the-counter vaginal contraceptive and spermicide drug products containing nonoxynol 9; required labeling. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Dec; 72(243):71769-85. PubMed ID: 18159651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion.
    D'Cruz OJ; Yiv SH; Uckun FM
    AAPS PharmSciTech; 2001 Apr; 2(2):E5. PubMed ID: 14727880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new model for collaboration: the alliance for microbicide development.
    Harrison PF
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S39-53. PubMed ID: 10661740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study.
    Mauck CK; Weiner DH; Ballagh SA; Creinin MD; Archer DF; Schwartz JL; Pymar HC; Lai JJ; Rencher WF; Callahan MM;
    Contraception; 2004 Jul; 70(1):77-83. PubMed ID: 15208057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.